End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
95,600 KRW | -0.31% | +6.34% | +3.69% |
16/01 | Celltrion Holdings Actively Pursuing Nasdaq Listing | MT |
02/01 | Celltrion's Shares Climb After Merger With Affiliate | DJ |
Business Summary
Number of employees: 328
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 386,040 | 100.0 % | 388,794 | 100.0 % | +0.71% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
98.6
%
| 383,320 | 99.3 % | 383,501 | 98.6 % | +0.05% |
Singapore
1.0
%
| - | - | 3,709 | 1.0 % | - |
Kazakhstan
0.2
%
| 1,447 | 0.4 % | 950 | 0.2 % | -34.37% |
Other
0.1
%
| 191 | 0.0 % | 343 | 0.1 % | +79.42% |
Philippines
0.1
%
| 930 | 0.2 % | 292 | 0.1 % | -68.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeong-Soo Suh
CEO | Chief Executive Officer | 64 | 28/16/28 |
Yu-Jin Jeon
DFI | Director of Finance/CFO | 51 | - |
Jung-Jin Seo
CHM | Chairman | 66 | 23/09/23 |
Young-Sub Lee
AUD | Comptroller/Controller/Auditor | 58 | - |
Seong-Hoon Jung
SAM | Sales & Marketing | 53 | - |
Tae-Jin Kim
PRN | Corporate Officer/Principal | 61 | 01/12/01 |
Dong-Ho Lim
AUD | Comptroller/Controller/Auditor | 70 | 22/12/22 |
Seung-Jae Choi
PRN | Corporate Officer/Principal | 58 | 04/10/04 |
Jin-Kyu Wang
PRN | Corporate Officer/Principal | 60 | 01/12/01 |
Hyuk-Seong Kwon
SAM | Sales & Marketing | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 66 | 23/09/23 |
Jeong-Soo Suh
CEO | Chief Executive Officer | 64 | 28/16/28 |
Haeng-Ok Kim
BRD | Director/Board Member | 72 | 28/14/28 |
Gyeong-Yeop Kim
BRD | Director/Board Member | 67 | 25/13/25 |
Wang-Don Lee
BRD | Director/Board Member | 68 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,585,174 | 19,555,477 ( 47.03 %) | 175,417 ( 0.4218 %) | 47.03 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CELLTRION PHARM, INC. 0.42% | 175,417 | 0.42% | 13,694,579 $ |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+3.69% | 2.92B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- A068760 Stock
- Company Celltrion Pharm, Inc.